David Choe is a pharmacist who is specialized in Ambulatory Care in Dallas, Texas. Patients can reach him at 5184 Tex Oak Ave, Dallas or contact him on 469-419-1830. Active license number of David Choe is 40007 for Ambulatory Care in Texas. David Choe is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
David Choe speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
David Choe
Specialization:
Ambulatory Care
Credentials:
PHARMD
Gender:
Male
Location:
5184 Tex Oak Ave, Dallas, Texas, 75235-7822
Phone:
469-419-1830
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of David Choe are as mentioned below.
NPI Number:
1629795174
NPI Enumeration Date:
25 Oct, 2022
NPI Last Update On:
25 Oct, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for David Choe are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
40007
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5184 Tex Oak Ave, Dallas, Texas
Zip:
75235-7822
Phone Number:
469-419-1830
Fax Number:
--
Patients can reach David Choe at 5184 Tex Oak Ave, Dallas, Texas or can call on phone at 469-419-1830.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.